Unnamed-0,Unnamed-1,Three-Months-Ended,Unnamed-3
,"December 31, 2019","September 29,2019","December 31, 2018"
,,"(Unaudited, in millions)",
Research and development funding,$68,$14,$19
Phase-out and start-up costs,(16),(15),(1)
"Exchange gain (loss), net",1,(1),—
Patent costs,(1),(1),(1)
Gain on sale of non-current assets,1,—,1
"Other, net",1,1,(2)
"Other income and expenses, net",$54,$(2),$16
As percentage of net revenues,2.0%,(0.1)%,0.6%
